Posted by Michael Wonder on 18 Nov 2020
Pfizer has enough safety data about its coronavirus vaccine and is preparing to submit for FDA authorisation, CEO says
17 November 2020 - Pfizer has accumulated enough safety data on its COVID-19 vaccine and is preparing to file for emergency use authorisation from the US FDA, company CEO Albert Bourla said Tuesday.
Last week, the company released early clinical trial data showing its vaccine is more than 90% effective, and said it was waiting to apply to the FDA until it had gathered sufficient data on the safety of the vaccine.
